` LFCR (Lifecore Biomedical Inc) vs S&P 500 Comparison - Alpha Spread

LFCR
vs
S&P 500

Over the past 12 months, LFCR has outperformed S&P 500, delivering a return of 27% compared to the S&P 500's 8% growth.

Stocks Performance
LFCR vs S&P 500

Loading

Performance Gap
LFCR vs S&P 500

Loading
LFCR
S&P 500
Difference

Performance By Year
LFCR vs S&P 500

Loading
LFCR
S&P 500
Add Stock

Competitors Performance
Lifecore Biomedical Inc vs Peers

Lifecore Biomedical Inc
Glance View

Market Cap
243.3m USD
Industry
Food Products

Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.

LFCR Intrinsic Value
10.02 USD
Undervaluation 34%
Intrinsic Value
Price
Back to Top